We identified that silencing cPKM in ICC cells with a siRNA inhibited the expression of STMN1, weakened the proliferation and metastasis ability of ICC cells, and sensitized them to paclitaxel. The gene discussed is CKM; the disease is intrahepatic cholangiocarcinoma.